eu-authorized-representative - Knowing The Best For You

EU Authorised Representative for Medical Devices and IVDs Across Europe


For manufacturers based outside the European Union, placing medical devices or in vitro diagnostic devices in Europe requires more than product quality, technical files and regulatory planning. Before any device is introduced to the European market, the manufacturer must appoint an EU Authorized Representative who is physically located in the European Union and legally recognised as the manufacturer’s official representative. This role is essential under the Medical Device Regulation and the In Vitro Diagnostic Medical Device Regulation because regulators need a responsible local party who can communicate, provide documentation and support compliance activities when required. An eu-authorized-representative is not simply a name on a label. The representative acts as the legal presence of a non-EU manufacturer and plays an important role in maintaining market access, regulatory confidence and post-market accountability.

Why an EU Authorized Representative Is Required


European medical device rules are designed to protect patients, healthcare professionals and users by ensuring that every product placed on the market has a clear chain of responsibility. If a manufacturer operates outside the European Union, regulators cannot always interact with them as easily as they would with a locally established company. This is exactly where the EU Authorized Representative becomes essential. The representative provides a formal local presence and serves as the official point of communication for Competent Authorities, Notified Bodies and other regulatory stakeholders.

Without designating an authorised representative, a non-EU manufacturer is not permitted to place medical devices or IVDs on the European market. This applies to a wide range of products, from simple low-risk devices to complex diagnostic technologies. The requirement exists before market entry, which means the representative must be appointed early in the compliance process rather than treated as a final administrative step. For companies preparing for European distribution, selecting the right EU Authorized Representative for Medical Devices and IVDs can significantly influence registration readiness, document management and long-term regulatory stability.

The Written Mandate Between Manufacturer and Representative


The connection between the manufacturer and the EU Authorized Representative must be formalised through a written mandate. This mandate defines the tasks the representative is authorised to perform and confirms the obligations both parties must follow. It is a key compliance document because it sets out the scope of representation, responsibilities, communication duties and actions required if compliance concerns arise.

A vague or poorly prepared mandate can create uncertainty at the worst possible time, especially during an authority request, inspection, complaint review or corrective action. A strong mandate should clearly describe how documents will be made available, how regulatory communication will be handled, how incident information will be shared and what happens if the manufacturer does not meet its duties. For this reason, the mandate should be prepared carefully and reviewed before device registration or market placement begins.

Label and Packaging Requirements


The name and address of the EU Authorized Representative must appear on the device label, packaging or related product information as required by the applicable regulation. This allows authorities, distributors, healthcare professionals and users to identify the local representative linked to the device. It also strengthens the representative’s role as the official European contact for a manufacturer based outside the European Union.

Accurate labelling is essential because incorrect or missing representative details can lead to compliance issues and possible delays in market access. Manufacturers should ensure that their artwork, instructions, declarations and registration information are aligned before products are released. If the representative is changed, labelling and registration details may also require timely and controlled updates.

Documentation Review and Availability


One of the important duties of an EU Authorized Representative for Medical Devices and IVDs is to verify that key compliance documents are available and properly prepared. This includes checking that the EU Declaration of Conformity exists, that technical documentation has been compiled and that the manufacturer has followed an appropriate conformity assessment route for the device type and risk class.

The representative may also be required to retain or access copies of technical files, declarations and Notified Body certificates. These documents must be available for inspection by Competent Authorities for the required retention period after the last device has been placed on the market. This places document control at the core of the manufacturer–representative relationship. Manufacturers should maintain updated records and ensure that the representative can respond quickly if regulators request information.

Communication With Competent Authorities and Notified Bodies


The EU Authorized Representative serves as the formal communication link between the non-EU manufacturer and European regulatory authorities. If a Competent Authority requests data, samples, technical files or clarification, the representative is responsible for assisting with the response. The representative may also communicate with Notified Bodies when required, especially where certificates, conformity assessment or corrective actions are involved.

This communication role requires more than forwarding messages. A reliable representative should understand regulatory expectations, keep accurate records and ensure that requests are handled within appropriate timelines. Delayed or incomplete responses can create serious issues for manufacturers, including market restrictions or further regulatory review. Therefore, manufacturers should partner with a representative who has strong regulatory expertise and well-defined internal systems.

Post-Market Surveillance and Incident Support


Medical device compliance does not end after market entry. Once a device is in use, manufacturers must continue monitoring performance, complaints, incidents and safety signals. The EU Authorized Representative supports this post-market obligation by promptly forwarding complaints and incident reports to the manufacturer.

This is especially important when information comes from clinicians, patients, users, distributors or authorities. Timely communication helps the manufacturer assess whether further investigation, reporting, field safety action or corrective action is needed. An effective representative recognises that post-market surveillance goes beyond documentation. It is part of patient safety, product improvement and ongoing regulatory trust.

Registration Responsibilities and EUDAMED


Within European regulatory frameworks, manufacturer and representative details must be registered as necessary. The EU Authorized Representative may support the registration of both the manufacturer and representative information in EUDAMED. Accurate registration helps authorities identify responsible parties, review device information and maintain market oversight.

Manufacturers should gather complete company information, device details, certificates and declarations before starting registration. Any mismatch between labelling, declarations, technical documentation and registration records may lead to delays or compliance concerns. The representative’s involvement helps ensure that required information is properly aligned and available when needed.

When the Representative Must Take Action


An EU Authorized Representative also has duties if the manufacturer fails to meet regulatory obligations. If significant non-compliance arises and is not corrected by the manufacturer, the representative may need to terminate the mandate and notify relevant authorities and the Notified Body where relevant. This responsibility highlights that the role extends beyond administrative tasks.

The representative holds legal responsibility and cannot overlook serious compliance breaches. Manufacturers should therefore treat the representative as a regulatory partner rather than a passive service provider. Open communication, timely document updates and clear responsibility sharing help prevent misunderstandings and reduce risk during the product life cycle.

Choosing the Right EU Authorized Representative


Selecting an EU Authorized Representative should be done with care. Manufacturers should look for regulatory competence, experience with medical devices and IVDs, document handling capability, clear response procedures and a strong understanding of European requirements. The representative should be able to support communication with authorities, maintain records and guide the manufacturer on practical compliance expectations.

Cost should not be the only factor. A weak representative can create delays, poor communication and unnecessary risk, while a capable representative can help maintain confidence throughout market entry and post-market activities. The correct selection provides non-EU manufacturers with a reliable European presence and enables smoother regulatory management.

Conclusion


An EU Authorized Representative is a mandatory requirement for non-EU manufacturers aiming to introduce medical devices or IVDs into the European market. The role covers eu-authorized-representative legal representation, document availability, regulatory communication, complaint management, registration assistance and intervention in cases of serious non-compliance. Under the Medical Device Regulation and In Vitro Diagnostic Medical Device Regulation, appointing an authorised representative is not optional and should be completed before market placement begins. By choosing a competent EU Authorized Representative for Medical Devices and IVDs, manufacturers can strengthen compliance, support patient safety and build a reliable foundation for long-term access to the European market.

Leave a Reply

Your email address will not be published. Required fields are marked *